Murata, S., Nakamura, M., Sugihara, K., Sakai, T., Ishioka, K., Takahashi, S., Sasada, S., Yasuda, H. and Fukunaga, K. 2022. The Change in Neutrophil-to-lymphocyte Ratio after Initiation of Nivolumab Monotherapy May be a Strong Marker of Response and Predictor of Prognosis in Advanced Non-small Cell Lung Carcinoma. Asian Pacific Journal of Cancer Care. 7, 1 (Mar. 2022), 191-196. DOI:https://doi.org/10.31557/apjcc.2022.7.1.191-196.